As expressed by others, it is imperative to ensure alignment between the TMF Reference Model and the OASIS eTMF Model.
The TMF Reference Model has been adopted or leveraged by many organizations and represents the input and experience of over 350 industry representatives from around 200 companies.
_________________________________
Lisa Rakebrand
Director, Clinical R&D
Janssen
Research & Development
Global Clinical Operations
700 Route 202 South, PO Box 300
Raritan, New Jersey 08869
Phone: (908) 927-6285
Fax: (609) 784-7918
Email: LRakebra@its.jnj.com
Confidentiality Notice:
This e-mail transmission may contain confidential or legally privileged information that is intended only for the individual or entity named in the e-mail address. If you are not the intended recipient, you are hereby notified that any disclosure, copying,
distribution, or reliance upon the contents of this e-mail is strictly prohibited. If you have received this e-mail transmission in error, please reply to the sender, so that Johnson & Johnson can arrange for proper delivery, and then please delete the message
from your inbox. Thank you.